These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 20019446)
21. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension. Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933 [TBL] [Abstract][Full Text] [Related]
22. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline. Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957 [TBL] [Abstract][Full Text] [Related]
24. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats. Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844 [TBL] [Abstract][Full Text] [Related]
25. Captopril attenuates matrix metalloproteinase-2 and -9 in monocrotaline-induced right ventricular hypertrophy in rats. Okada M; Kikuzuki R; Harada T; Hori Y; Yamawaki H; Hara Y J Pharmacol Sci; 2008 Dec; 108(4):487-94. PubMed ID: 19057128 [TBL] [Abstract][Full Text] [Related]
26. [The intervention of ginkgo biloba extract on monocrotaline-induced right ventricular hypertrophy in rats and its mechanism]. Chen HQ; Cai KF Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Feb; 35(2):169-172. PubMed ID: 31250611 [TBL] [Abstract][Full Text] [Related]
27. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension. Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591 [TBL] [Abstract][Full Text] [Related]
28. Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats. Leineweber K; Seyfarth T; Brodde OE Br J Pharmacol; 2000 Dec; 131(7):1438-44. PubMed ID: 11090118 [TBL] [Abstract][Full Text] [Related]
29. Characterization of fibroblasts from hypertrophied right ventricle of pulmonary hypertensive rats. Imoto K; Okada M; Yamawaki H Pflugers Arch; 2018 Sep; 470(9):1405-1417. PubMed ID: 29860638 [TBL] [Abstract][Full Text] [Related]
30. Ca Sabourin J; Boet A; Rucker-Martin C; Lambert M; Gomez AM; Benitah JP; Perros F; Humbert M; Antigny F J Mol Cell Cardiol; 2018 May; 118():208-224. PubMed ID: 29634917 [TBL] [Abstract][Full Text] [Related]
31. Changes in ventricular 1,2-diacylglycerol content in rats following monocrotaline treatment. Okumura K; Kondo J; Shimizu K; Yoshino M; Toki Y; Hashimoto H; Ito T Cardiovasc Res; 1992 Jun; 26(6):626-30. PubMed ID: 1280532 [TBL] [Abstract][Full Text] [Related]
32. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat. Zhang TT; Cui B; Dai DZ Acta Pharmacol Sin; 2004 Feb; 25(2):226-30. PubMed ID: 14769214 [TBL] [Abstract][Full Text] [Related]
33. Effects of exercise on monocrotaline-induced changes in right heart function and pulmonary artery remodeling in rats. Colombo R; Siqueira R; Becker CU; Fernandes TG; Pires KM; Valença SS; Souza-Rabbo MP; Araujo AS; Belló-Klein A Can J Physiol Pharmacol; 2013 Jan; 91(1):38-44. PubMed ID: 23368696 [TBL] [Abstract][Full Text] [Related]
34. Calcium mishandling impairs contraction in right ventricular hypertrophy prior to overt heart failure. Power AS; Hickey AJ; Crossman DJ; Loiselle DS; Ward ML Pflugers Arch; 2018 Jul; 470(7):1115-1126. PubMed ID: 29525825 [TBL] [Abstract][Full Text] [Related]
35. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080). Brunner F; Wölkart G; Haleen S J Pharmacol Exp Ther; 2002 Feb; 300(2):442-9. PubMed ID: 11805203 [TBL] [Abstract][Full Text] [Related]
36. Acceleration of Ca2+ waves in monocrotaline-induced right ventricular hypertrophy in the rat. Miura M; Hirose M; Endoh H; Wakayama Y; Sugai Y; Nakano M; Fukuda K; Shindoh C; Shirato K; Shimokawa H Circ J; 2011; 75(6):1343-9. PubMed ID: 21467666 [TBL] [Abstract][Full Text] [Related]
37. Myocardial force development and structural changes associated with monocrotaline induced cardiac hypertrophy and heart failure. Korstjens IJ; Rouws CH; van der Laarse WJ; Van der Zee L; Stienen GJ J Muscle Res Cell Motil; 2002; 23(1):93-102. PubMed ID: 12363290 [TBL] [Abstract][Full Text] [Related]